HF
HANMI FINANCIAL CORP (HAFC)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 delivered the strongest quarter of the year: diluted EPS $0.58 (+18.8% q/q; -4.9% y/y), net income $17.7M, on a 17 bps NIM expansion to 2.91% as the cost of interest-bearing deposits fell 31 bps to 3.96% while average loan yield was resilient at 5.97% .
- Total deposits rose 0.5% q/q to $6.44B with noninterest-bearing DDA up 2.2% and comprising 32.6% of deposits; loans were essentially flat at $6.25B; efficiency improved to 56.79% on lower funding costs and an OREO gain .
- Credit trends remained benign (net recoveries ~$0.1M; NPAs/Assets 0.19%), though criticized loans increased to $165.3M (special mention up; classified down) .
- Capital return accelerated: dividend raised 8% to $0.27 per share for 1Q25; TBVPS $23.88; CET1 12.11% (Company) .
- 2025 setup: management targets low-to-mid single-digit loan growth with deposit growth similar; significant CD repricing runway ($770M in 1Q25 at 4.70%; $685M in 2Q25 at 4.42%) supports further deposit cost declines and NIM tailwinds, offset by slight loan-yield drift and a modest uptick in criticized loans .
What Went Well and What Went Wrong
-
What Went Well
- Net interest margin expanded 17 bps to 2.91% on lower deposit costs; CFO highlighted deposit beta progress and January-to-date further declines in interest-bearing deposit rates vs 4Q average .
- Core funding mix improved: DDA grew 2.2% q/q to 32.6% of deposits; time deposits declined 2.0% q/q, supporting NIM and funding resilience .
- Asset quality remained strong: net loan recoveries of $0.1M; NPAs/Assets improved to 0.19%; NPLs fell to 0.23% of loans .
- CEO: “best quarterly performance of the year… NIM expansion of 17 basis points to 2.91%, disciplined expense management, and vigilant credit administration” .
- Dividend raised 8% to $0.27, signaling confidence in earnings power and capital .
-
What Went Wrong
- Noninterest income fell 12.8% q/q to $7.4M due to absence of prior-quarter $0.9M branch sale-leaseback gain; SBA and mortgage gains were roughly steady but volumes slipped .
- Criticized loans rose to $165.3M (+$5.3M q/q) driven by special mention additions (notably a $12.4M C&I retail relationship), offset by lower classified balances .
- Loan yield eased 3 bps q/q to 5.97%; Equipment Finance continued to experience charge-offs (gross $3.4M total, including $2.9M in E/F agreements), though net was a small recovery .
Financial Results
Versus estimates (Q4 2024)
- EPS (diluted): Reported $0.58; S&P Global consensus: N/A at time of request (API limit).
- Revenue (Operating Revenue): Reported $60.8M; S&P Global consensus: N/A at time of request (API limit).
Note: Consensus estimates from S&P Global were unavailable at time of analysis due to provider limit. We will update beat/miss once available.
Segment/Lending Mix (Balances and composition)
Deposit Mix (Period-end)
Key KPIs (trailing quarters)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “Hanmi achieved exceptional results in the fourth quarter… best quarterly performance of the year… NIM expansion of 17 basis points to 2.91%, disciplined expense management, and vigilant credit administration” .
- CEO: “Board approved an 8% increase in our quarterly dividend to $0.27… underscores our confidence in our growth strategy” .
- CFO: “Net interest income increased 6.8%… net interest margin increased 17 bps to 2.91%… decline in the average rate paid on interest-bearing deposits… 3.96%, down 31 bps q/q… January to date [rates] down 25 bps vs 4Q average” .
- CBO: “4Q loan production $339M at 7.37%; CRE $147M… USKC accounted for $91M of production; lines of credit commitments $1.8B, outstanding balances +27% y/y” .
Q&A Highlights
- Deposit repricing runway: ~$770M CDs maturing in 1Q25 at 4.70% and ~$685M in 2Q25 at 4.42%; Q4 benefited from repricing (IB deposit cost to 3.96%) .
- Floating-rate exposure: “Floaters ~10% or less” of loans; loan yields resilient given mix (SBA reprices quarterly; resi ARMs; smaller CRE with 5-year fixed, then float) .
- SBA portfolio: ~ $250M exposure; management emphasized focus on past performance vs projected cash flows and minimal reliance on brokers .
- Expenses: run-rate to generally move with inflation; Q1 advertising/promo seasonal down, merit increases in Q2 .
- 2025 trajectory: targeting low-to-mid single digit loan growth; deposit growth “similar” .
Estimates Context
- S&P Global consensus (EPS, revenue) was unavailable at the time of this analysis due to provider request limits; therefore, we cannot declare a beat/miss. We will update once S&P data is accessible.
- Management’s commentary and operating trends (deposit cost declines, CD roll-down, stable loan yields) suggest near-term upward bias to NIM and pretax pre-provision income, absent adverse credit migration .
Key Takeaways for Investors
- Funding-cost inflection is underway: cost of interest-bearing deposits fell 31 bps q/q and is trending lower in January, positioning NIM for further improvement as ~$1.5B of CDs reprice in 1H25 .
- Core funding strengthening: DDA rose to 32.6% of deposits; time deposits down 2% q/q—favorable for margin durability in a declining-rate backdrop .
- Credit remains solid with low losses and improved NPAs, but the rise in special mention balances (criticized loans) warrants monitoring, particularly in select C&I and hospitality exposures; equipment finance charge-offs remain a watch item .
- Mix strategy working: USKC/Corporate Korea initiative now 15% of loans (23% y/y growth) with Seoul representative office enhancing pipeline; supports C&I growth and sticky operating deposits .
- Capital return improving: 8% dividend increase to $0.27 and ongoing buybacks indicate confidence in earnings power and capital resilience (CET1 12.11%) .
- Near-term setup: Expect stable-to-improving PPNR driven by NIM tailwinds and disciplined expenses, with modest loan growth and payoff headwinds balancing production; watch criticized trends and equipment finance .
- Potential catalysts: sustained NIM expansion, stable credit metrics, further DDA gains, and visible progress in USKC growth could be stock positives; any deterioration in criticized loans or weaker fee income could weigh on sentiment .
Appendix: Additional Context and Prior Quarters
- Q3 2024: EPS $0.49; NIM 2.74%; operating revenue $58.5M; DDA 32.0%; criticized loans up to $160.0M; noninterest income boosted by $0.9M branch sale-leaseback .
- Q2 2024: EPS $0.48; NIM 2.69%; production +17% q/q; criticized loans down q/q; deposit costs rising then .
Sources:
- Q4 2024 8-K (Press Release & Supplemental): .
- Q4 2024 Earnings Call Transcript: .
- Q3 2024 Press Release: .
- Q2 2024 Press Release: .
- Nov 18, 2024 USKC Seoul Office Press Release: .
- Dividend Increase Press Release (Jan 28, 2025): .